Company news
Oric Pharmaceuticals, Inc. news in 2023
Oric Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination Development
December 10, 2023
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
November 5, 2023
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
November 1, 2023
Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile
October 20, 2023
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023
October 16, 2023
ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
August 9, 2023
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 3, 2023
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
June 25, 2023
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
May 30, 2023
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
May 7, 2023
ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference
April 24, 2023
ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting
April 17, 2023
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
March 15, 2023
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 13, 2023
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
March 5, 2023
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
January 8, 2023
ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 2, 2023